Showing results (891-900 of 1,301) with videos related to
Sort By:
Pageof 131
The Journal of Biological Chemistry|September 2, 2015
Perturbation of the Vacuolar ATPase: A NOVEL CONSEQUENCE OF INOSITOL DEPLETIONRania M Deranieh, Yihui Shi, Maureen Tarsio, et al.BMC Medical Education|December 2, 2022
Medical student exam performance and perceptions of a COVID-19 pandemic-appropriate pre-clerkship medical physiology and pathophysiology curriculumMelissa Chang, Andrew Cuyegkeng, Joseph A Breuer, et al.Neuropsychology|November 25, 2010
Multimodal cuing of autobiographical memory in semantic dementiaDaniel L Greenberg, Jennifer M Ogar, Indre V Viskontas, et al.International Journal of Public Health|December 20, 2013
Screening for coronary heart disease and diabetes risk in a dental settingMythili Kalladka, Barbara L Greenberg, Shreenivasa Murthy Padmashree, et al.Indian Pacing and Electrophysiology Journal|October 26, 2017
Pseudo cryomapping for ablation of atrioventricular nodal reentry tachycardia: A single center North American experienceVaibhav K Moondra, Mark L Greenberg, Barbara R Gerling, et al.Psychiatry Research|August 29, 2006
Differences in brain volumes among males and female hormone-therapy users and nonusersDaniel L Greenberg, Martha E Payne, James R MacFall, et al.AIDS (London, England)|September 21, 2000
Considerations in choosing a primary endpoint that measures durability of virological suppression in an antiretroviral trialP B Gilbert, H J Ribaudo, L Greenberg, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 11, 2000
Transesophageal echocardiography assessment of severe ostial left main coronary stenosisM S Firstenberg, N L Greenberg, S S Lin, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 30, 2005
A pilot study of ondansetron plus metopimazine vs. ondansetron monotherapy in children receiving highly emetogenic chemotherapy: a Bayesian randomized serial N-of-1 trials designP C Nathan, G Tomlinson, L L Dupuis, et al.Medical and Pediatric Oncology|January 1, 1991
Neuroblastoma stage IV-S: a heterogeneous diseaseP C Wilson, M J Coppes, H Solh, et al.Pageof 131